Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Case 2: Initiating ART in a Treatment-Naive Patient With Comorbidities and Drug–Drug Interactions

Source: HIV-ASSIST: A New Tool to Guide Evidence-Based Selection of Antiretroviral Therapy
Faculty demonstrate the use of HIV-ASSIST in choosing appropriate ART in a treatment-naive patient with comorbidities and potential drug–drug interactions.
Jonathan Li, MD
Maunank Shah, MD, PhD
Released: February 4, 2021 Expiration: No longer available for credit

This program is divided into several short segments which you can step through using the Video Chapters menu.

Video Chapters

Why Use HIV-ASSIST?
How HIV-ASSIST Works
Validation of HIV-ASSIST
Case 1: Treatment-Naive
Case 2: Comorbidity, DDI
Case 3: ARV Resistance
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Theratechnologies Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings